Pure Global AI
NCT06354777Not yet recruiting

REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry

REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-study of the REAL AF Registry
Heart Rhythm Clinical and Research Solutions, LLCClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Atrial Fibrillation
Drug/Device/Intervention
Ablation Procedure
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Heart Rhythm Clinical and Research Solutions, LLC
Timeline & enrollment
Phase
N/A
Start date
Apr 15, 2024
End date
Dec 30, 2024
Enrollment
312 participants
Primary outcome

To measure procedural efficacy after atrial fibrillation ablation in patients treated with active esophageal cooling.,To measure procedural efficacy after atrial fibrillation ablation in patients treated with active esophageal cooling.,To measure long term safety after atrial fibrillation in patients treated with active esophageal cooling.,Patient reported outcomes in patients treated with active esophageal cooling.,Physician reported outcome post procedure with active esophageal cooling.

Summary

This is a multi-center sub-study examining the effectiveness of active esophageal cooling on
 subjects undergoing left atrial ablation for symptomatic Paroxysmal Atrial Fibrillation or
 Persistent Atrial Fibrillation.

ICD-10 classifications
Chronic atrial fibrillationPersistent atrial fibrillationParoxysmal atrial fibrillationAtrial fibrillation and flutterAtrial fibrillation and atrial flutter, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06354777
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06354777 through Pure Global AI's free database. This phase not specified trial is sponsored by Heart Rhythm Clinical and Research Solutions, LLC and is currently Not yet recruiting. The study focuses on Atrial Fibrillation. Target enrollment is 312 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.